Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Adverum Biotechnologies Inc.
DescriptionIntravitreally delivered vector with an optimize adeno-associated virus (AAV) capsid, expression cassette, and anti-VEGF cDNA
Molecular Target Soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) (sVEGFR-1)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today